Skip to content

MBCP Safety and Performance in the Osteonecrosis of Femur Head

Evaluation of Safety and Performance of Macroporous Biphasic Calcium Phosphate Granules Combined With Cellulosic-Derived Gel, in Filling Bones Gap After Aseptic Osteonecrosis Biopsy of Femur Head.

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00289575
Enrollment
12
Registered
2006-02-10
Start date
2006-02-28
Completion date
2008-02-29
Last updated
2007-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteonecrosis

Keywords

Femur head aseptic osteonecrosis, Bone reconstruction, Macroporous biphasic calcium phosphate granules

Brief summary

The aim of this pilot study is to evaluate MBCP performance in bone regeneration after osteonecrosis biopsy of the femur head. This technic may prevent the neck of the femur bone weakness following the healthy area drilling, thanks to a bone reconstruction at the expense of the biomaterial.

Detailed description

Twelve patients will be enrolled in this study and evaluation of infection and inflammation of the drilled area, pain and hip function will be assessed during a one year follow up. Bone reconstruction will be evaluated with scanner and radiography.

Interventions

DEVICEMBCP

Sponsors

CIC Bordeaux
CollaboratorUNKNOWN
Biomatlante
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* femur head osteonecrosis (1 to 2 level in ARCO scale) * signed informed consent

Exclusion criteria

* primary bone infection * femur head sphericity loss * cancer, diabetes, tuberculosis previous history * HIV, Hepatitis B, Hepatitis C infection * drepanocytosis * current corticotherapy * current immunosuppressive therapy * innate or acquired immune deficience * pregnancy or lack of efficient contraception * current participation in an other study

Design outcomes

Primary

MeasureTime frame
Infection and inflammation of the drilled area (blood and clinical assessment).
Adverse events.

Secondary

MeasureTime frame
Bone reconstruction evaluation through scanner and radiography
Pain (Analogic Visual Scale)
Hip function

Countries

France

Contacts

Primary ContactThierry FABRE, Pr
thierry.fabre@chu-bordeaux.fr+33556795544
Backup ContactDominique CHAUVEAUX, Pr
dominique.chauveaux@chu-bordeaux.fr+33556795679

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026